• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall 30ML 2PORT BURETTE ASSEMBLY

  • Print
  • Share
  • E-mail
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC

New Search Back to Search Results
  Class 2 Device Recall 30ML 2PORT BURETTE ASSEMBLY see related information
Date Initiated by Firm September 26, 2023
Date Posted November 03, 2023
Recall Status1 Open3, Classified
Recall Number Z-0131-2024
Recall Event ID 93074
Product Classification Injector and syringe, angiographic - Product Code DXT
Product 30 ML 2PORT BURETTE ASSEMBLY, Article No. 7A3950, used in a contrast management system.
Code Information UDI-DI: N/A Lots 0061766049
Recalling Firm/
B. Braun Medical, Inc.
901 Marcon Blvd
Allentown PA 18109-9512
For Additional Information Contact BBMI Postmarket Surveillance Department
Manufacturer Reason
for Recall
Devices may leak as a result of a manufacturing issue. Leakage may result in a delay of therapy, increase risk of bloodstream infection (BSI), and may expose both patients and healthcare workers to hazardous medication. There is also the potential for life-threatening situations to occur requiring additional medical intervention.
FDA Determined
Cause 2
Process control
Action On September 26, 2023, the firm notified customers via Urgent Product Recall Notification letters. Customers were informed of the potential for leakage at the male Luer lock site. Customers were instructed to report total amount of impacted product on hand to the firm, after which B Braun Customer Support will contact the customer with instructions on how to return the product for credit or replacement depending on the customer's need. Questions about this recall may be reported to BBMI s Postmarket Surveillance Department by calling 1-833-425-1464.
Quantity in Commerce 350 units
Distribution Worldwide distribution - US Nationwide and the countries of Canada and Singapore.
Total Product Life Cycle TPLC Device Report

1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.